Koka, Japan

Shinji Maegata

This inventor holds 2 USPTO granted patents. Top assignees: Takeda Chemical Industries, Inc., Other. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Maegata. Retrieved from https://idiyas.com/inventor/shinji-maegata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shinji Maegata: Innovator in Pharmaceutical Excipients

Introduction

Shinji Maegata is a notable inventor based in Koka-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of excipients. With a total of 2 patents to his name, Maegata's work has had a meaningful impact on the industry.

Latest Patents

Maegata's latest patents focus on D-mannitol and its preparation. One of his patents discloses D-mannitol having a specific surface area of not less than about 1 m²/g. This D-mannitol shows improved compressibility and is useful as an excipient. The second patent also pertains to D-mannitol, emphasizing its specific surface area and its benefits in pharmaceutical applications.

Career Highlights

Throughout his career, Maegata has worked with prominent companies, including Takeda Chemical Industries, Inc. His experience in these organizations has allowed him to refine his expertise in the development of pharmaceutical excipients.

Collaborations

Maegata has collaborated with several professionals in his field, including Tomohiro Yoshinari and Fritz Schueckler. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Shinji Maegata is a distinguished inventor whose work in D-mannitol has enhanced the pharmaceutical industry. His patents reflect his commitment to improving excipients, which are crucial for drug formulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…